Pharmaceutical compositions for ulcer
US6436975B1 · kind B1 · utility
17Cited by
1References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 29, 2000 |
| Grant date | Aug 20, 2002 |
| Priority date | — |
| Expiry date | Aug 29, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions for the therapy and the prevention of ulcer and dyspepsia relapses comprising as essential components the following components a) and b): component a): one or more components selected from the conventional anti-ulcer products; component b): organic compounds containing the —ONO2 function, or inorganic compounds containing the —NO group, characterized in that they are NO nitric oxide donors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.